| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 07/31/2003 | WO2002039885A3 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 07/31/2003 | WO2002029038A3 Novel proteins and nucleic acids encoding same and antibodies directed against these proteins |
| 07/31/2003 | WO2002024909A3 Receptor nucleic acids and polypeptides |
| 07/31/2003 | WO2002018444A3 Erbb4 antagonists |
| 07/31/2003 | WO2002012286A3 Stress proteins and peptides and methods of use thereof |
| 07/31/2003 | WO2001098339A3 Compositions and methods for the therapy and diagnosis of breast cancer |
| 07/31/2003 | WO2001062298A9 Compositions and methods for treatment of angiogenesis in pathological lesions |
| 07/31/2003 | US20030145352 Nucleic acid molecules from rice and their use for the production of modified starch |
| 07/31/2003 | US20030144495 Drosophila recombination-associated protein and methods for use |
| 07/31/2003 | US20030144493 Human serine protease |
| 07/31/2003 | US20030144492 Anticancer agents; central nervous system disorders; antiinflammatory agents |
| 07/31/2003 | US20030144491 Methods and materials relating to cadherin-like polypeptides and polynucleotides |
| 07/31/2003 | US20030144486 Monoclonal human natural antibodies |
| 07/31/2003 | US20030144485 Monoclonal human natural antibodies |
| 07/31/2003 | US20030144484 Polynucleotides; immunoassay, immunotherapy |
| 07/31/2003 | US20030144483 Humanized antibodies to Fc receptors for immunoglobulin G on human mononuclear phagocytes |
| 07/31/2003 | US20030144482 Diagnosis of skin cancer; vaccine |
| 07/31/2003 | US20030144481 Controlling angiogenesis; controlling cell differentiation, proliferation |
| 07/31/2003 | US20030144480 Genetic engineering; medical diagnosis |
| 07/31/2003 | US20030144479 Biologically active compounds and methods of constructing and using the same |
| 07/31/2003 | US20030144473 Peptides for the production of preparations for the diagnosis and therapy of autoimmun diseases |
| 07/31/2003 | US20030144237 Antagonist for synergistic treatment of a thromboembolic disease |
| 07/31/2003 | US20030144194 Cancer treatment and prognosis |
| 07/31/2003 | US20030144192 Crystal proteins which exhibit insecticidal activity against coleopteran insects including red flour beetle larvae (Tribolium castaneum) and Japanese beetle larvae (Popillia japonica) |
| 07/31/2003 | US20030144188 Androgen regulated nucleic acid molecules and encoded proteins |
| 07/31/2003 | US20030144187 Comprising an osteoprotegerin polypeptide and an immunoglobulin FC region; treatment of bone disorders |
| 07/31/2003 | US20030144182 CD40-Ligand lacking native-pattern glycosylation |
| 07/31/2003 | US20030144165 For use in detergents and in baking |
| 07/31/2003 | US20030143760 Diagnosing brain diseases |
| 07/31/2003 | US20030143759 Measuring in an assay containing the sample and a substrate for activated protein c, the conversion of the substrate by activated protein c and correlating to the functional activity |
| 07/31/2003 | US20030143738 Compositions and methods for treating ischemic stroke |
| 07/31/2003 | US20030143735 Contacting human vpr interacting protein with a test compound and comparing the affinity of the vpr in the presence and absence of it |
| 07/31/2003 | US20030143707 Proteins having DNA repair promoting activity |
| 07/31/2003 | US20030143706 Novel human leucine-rich repeat containing protein expressed predominately in bone marrow, HLRRBM1 |
| 07/31/2003 | US20030143697 Nucleic acid encoding a fusion polypeptide that forms a multimer that binds to a cytokine to form a nonfunctional complex; cytokine antagonists for the treatment of cytokine-related diseases or disorders |
| 07/31/2003 | US20030143693 Growing, under suitable conditions, procaryotic or eucaryotic host cells transformed or transfected with a specific DNA, and isolating the desired polypeptide product of the expression of such DNA sequence |
| 07/31/2003 | US20030143690 Peptides and proteins that effect protein phosphorylation; genetic engineered DNA; useful for therapy and diagnosis |
| 07/31/2003 | US20030143685 Nucleic acid expression control sequence cassettes comprising a stable bacteriophage T5 promoter and nucleic acid regulatory sequences, useful for generating stable expressin vectors of high-level protein expression; culture product |
| 07/31/2003 | US20030143684 Combining a compound to be tested, a host cell expressing a recombinant protein containing a mammalian C-C chemokine receptor 3 and a ligand for binding of ligand to such receptor, detecting the formation of a receptor-ligand complex |
| 07/31/2003 | US20030143683 Introducing a nucleotide sequence encoding prefered amino acid sequences in into a host cell and culturing the host cell in which the peptides are expressed from the nucleotide sequence; human therapeutics and diagnostic protein |
| 07/31/2003 | US20030143682 Substituting an amino acid within the variable domain of the heavy or light chain of the monoclonal antibody wherein above amino acid containing a nonpolar side chain, with a proline |
| 07/31/2003 | US20030143679 Genes encoding insect odorant receptors and uses thereof |
| 07/31/2003 | US20030143676 Receptor polypeptides and polynucleotides encoding such polypeptides; for treating a disorder characterized by an elevated level of osteopontin |
| 07/31/2003 | US20030143674 Polypeptides fused to heterologous polypeptide sequences, and an antibodies which bind to the above polypeptides |
| 07/31/2003 | US20030143672 Providing conservative or semi-conservative amino acid substitutions at positions 3 and/or 5 and/or 7 of these epitopes, useful in eliciting immune responses with respect to corresponding wildtype epitopes |
| 07/31/2003 | US20030143667 Repeat sequences of the CA125 gene and their use for diagnostic and therapeutic interventions |
| 07/31/2003 | US20030143665 Calcium independent receptor of alpha-latrotoxin,characterization and uses thereof |
| 07/31/2003 | US20030143655 For competitive immunoassays for detection of lysergic acid (LAD) metabolite; drug screening; forensics |
| 07/31/2003 | US20030143654 Which participates in the ubiquitin-dependent proteolytic pathway that targets regulatory proteins for rapid intracellular degradation |
| 07/31/2003 | US20030143653 Method and kit for detecting, or determining the quantity of, beta-lactam penicillins |
| 07/31/2003 | US20030143642 Secretions of proteins by encapsulated cells |
| 07/31/2003 | US20030143638 Comprises protein, carbohydrate, and/or lipid as carrier bonded to Fc-sites of antibodies |
| 07/31/2003 | US20030143623 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 07/31/2003 | US20030143622 Human RNA binding proteins |
| 07/31/2003 | US20030143611 Cloning the DNA sequence encoding recombinant SRTA-70 proteins |
| 07/31/2003 | US20030143603 Anti-TNF antibodies, compositions, methods and uses |
| 07/31/2003 | US20030143595 Isolated and/or recombinantly produced polypeptide; use in regulating spermatogenesis, cell differentiation and proliferation |
| 07/31/2003 | US20030143589 Drug metabolizing enzymes |
| 07/31/2003 | US20030143588 Phosphodiesterases |
| 07/31/2003 | US20030143533 Methods and compositions utilizing rad51 |
| 07/31/2003 | US20030143245 Multivalent streptococcal vaccine compositions and methods for use |
| 07/31/2003 | US20030143241 For inhibiting hepatitis E virus (HEV) infection |
| 07/31/2003 | US20030143238 Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis |
| 07/31/2003 | US20030143236 For irreversibly inhibiting infectivity of a mammalian cell by a human rhinovirus |
| 07/31/2003 | US20030143234 For therapy of microbial organism infection |
| 07/31/2003 | US20030143233 For use in diagnosis, therapy |
| 07/31/2003 | US20030143232 Incubating survivin and p34cdc2-cyclin B1 kinase complex in presence of an agent; determining whether agent modulates phosphorylation of survivin by p34cdc2-cyclin B1 kinase complex, identifying an agent which modulates phosphorylation |
| 07/31/2003 | US20030143229 FAPalpha -specific antibody with improved producibility |
| 07/31/2003 | US20030143226 For therapy of arteriosclerosis, thrombocytopenia, kidneyd iseases, various types of inflammation such as myocardial ischemic reperfusion injury, inflammatory reactions after percutaneous transluminal coronary recanalization (PTCR)) |
| 07/31/2003 | US20030143225 Administering a dose of anti-tissue factor antibody and a suboptimal dose of at least one additional anticoagulant selected from the group consisting of heparin, low molecular weight heparin, pentasaccharide thrombin inhibotrs |
| 07/31/2003 | US20030143224 Antibodies specific for ungulate PrP |
| 07/31/2003 | US20030143222 Method of producing igg |
| 07/31/2003 | US20030143221 Method for producing vaccines containing a heat-treated mixture consisting of at least one antigen and of at least one adjuvant |
| 07/31/2003 | US20030143220 Hybrid immunoglobulins |
| 07/31/2003 | US20030143216 For therapy of fungal infections; for detecting chitin, binding chitin |
| 07/31/2003 | US20030143196 To regulate an immune response in an animal |
| 07/31/2003 | US20030143194 Antagonists of HMG1 for treating inflammatory conditions |
| 07/31/2003 | US20030143193 Compositions and methods for modifying toxic effects of proteinaceous compounds |
| 07/31/2003 | US20030143190 For modulating the immune system; therapy of cancer |
| 07/31/2003 | US20030143157 Method of treating tumors |
| 07/31/2003 | CA2732012A1 Genetic sequences having methyltransferase activity and uses therefor |
| 07/31/2003 | CA2476773A1 Monoclonal antibodies against extracellular loops of c5ar |
| 07/31/2003 | CA2474623A1 Peptides and nucleic acids of the cathelicidin family, derived from fish, and uses thereof |
| 07/31/2003 | CA2474259A1 Antibodies against and compositions containing new amphetamine derivatives |
| 07/31/2003 | CA2474030A1 Transgenic animal comprising intracellular immunoglobins for xenotransplantation |
| 07/31/2003 | CA2473786A1 Method of prophylaxis against large myocardial infarctions |
| 07/31/2003 | CA2473781A1 Glycoisoforms of adiponectin and uses thereof |
| 07/31/2003 | CA2473707A1 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof |
| 07/31/2003 | CA2472186A1 Combination il-2/anti-her2 antibody therapy for cancers characterized by overexpression of the her2 receptor protein |
| 07/31/2003 | CA2454358A1 Multimeric proteins and methods of making and using same |
| 07/31/2003 | CA2438698A1 Immunogen adherence inhibitor and method of making and using same |
| 07/30/2003 | EP1331483A1 Agent for detecting cancer's ability to metastasize |
| 07/30/2003 | EP1331268A1 Novel proteins, genes encoding them and method of using the same |
| 07/30/2003 | EP1331266A1 Cells producing antibody compositions |
| 07/30/2003 | EP1331265A2 density enhanced protein tyrosine phosphatases |
| 07/30/2003 | EP1331219A1 New amphetamine derivatives, antibodies against them and pharmaceutical compositions containing them |
| 07/30/2003 | EP1330651A2 Evaluating binding affinities by force stratification and force planning |
| 07/30/2003 | EP1330543A2 Nucleic acid sequences differentially expressed in cancer tissue |
| 07/30/2003 | EP1330522A1 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 07/30/2003 | EP1330521A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |